Impact of statin adherence on cardiovascular disease and mortality outcomes: a systematic review - Wikidata - wikimedia - TriplyDB

Impact of statin adherence on cardiovascular disease and mortality outcomes: a systematic review

Impact of statin adherence on cardiovascular disease and mortality outcomes: a systematic review

http://www.wikidata.org/entity/Q34554376

about

Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management Patient opinions on medicine-use review: exploring an expanding role of community pharmacists.Clinical Characteristics and Unmet Need Among Patients with Atherosclerotic Cardiovascular Disease Stratified by Statin Use Investigating the prevalence, predictors, and prognosis of suboptimal statin use early after a non-ST elevation acute coronary syndrome.ANMCO/GICR-IACPR/SICI-GISE Consensus Document: the clinical management of chronic ischaemic cardiomyopathy Identification and Management of Statin-Associated Symptoms in Clinical Practice: Extension of a Clinician Survey to 12 Further Countries Effects of generic substitution on refill adherence to statin therapy: a nationwide population-based study Meta-Analysis of Studies Comparing Single and Multi-Tablet Fixed Dose Combination HIV Treatment Regimens Renin-Angiotensin System Blockade Associated with Statin Improves Endothelial Function in Diabetics.Time trends in statin utilisation and coronary mortality in Western European countries.Atorvastatin treatment and LDL cholesterol target attainment in patients at very high cardiovascular risk.Assessing the feasibility and quality of shared decision making in China: evaluating a clinical encounter intervention for Chinese patients.Communication practices and awareness of resources for acromegaly patients among endocrinologists.Statin utilisation in a real-world setting: a retrospective analysis in relation to arterial and cardiovascular autonomic function Patterns and Predictors of Adherence to Statin Therapy Among Older Patients: Protocol for a Systematic Review.Excessive range of statin dose in Western Australian primary care.Refill adherence and persistence to lipid-lowering medicines in patients with type 2 diabetes: A nation-wide register-based study.Utilization of Statins Beyond the Initial Period After Stroke and 1-Year Risk of Recurrent Stroke.Can illness beliefs, from the common-sense model, prospectively predict adherence to self-management behaviours? A systematic review and meta-analysis.A systematic review to assess adherence and persistence with statins.ANMCO/ISS/AMD/ANCE/ARCA/FADOI/GICR-IACPR/SICI-GISE/SIBioC/SIC/SICOA/SID/SIF/SIMEU/SIMG/SIMI/SISA Joint Consensus Document on cholesterol and cardiovascular risk: diagnostic-therapeutic pathway in Italy.The art of modeling adherence: shades or shapes?Common statin side effects explain poor compliance.Effects of 12-week supplementation of Citrus bergamia extracts-based formulation CitriCholess on cholesterol and body weight in older adults with dyslipidemia: a randomized, double-blind, placebo-controlled trial.Effects of 12-week supplementation of marine Omega-3 PUFA-based formulation Omega3Q10 in older adults with prehypertension and/or elevated blood cholesterol.Treatment patterns and low-density lipoprotein cholesterol (LDL-C) goal attainment among patients receiving high- or moderate-intensity statins.Number of patients needed to prescribe statins in primary cardiovascular prevention: mirage and reality.Coronary Plaque Progression and Regression in Asymptomatic African American Chronic Cocaine Users With Obstructive Coronary Stenoses: A Preliminary Study.The pharmacodynamic and clinical trial evidence for statin dose.Motivational Interviewing and Medication Review in Coronary Heart Disease (MIMeRiC): Protocol for a Randomized Controlled Trial Investigating Effects on Clinical Outcomes, Adherence, and Quality of Life.Situational Analysis of Low-density Lipoprotein Cholesterol Control and the Use of Statin Therapy in Diabetes Patients Treated in Community Hospitals in Nanjing, China.2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia.Community Pharmacy-Based Inducement Programs Associated With Better Medication Adherence: A Cohort Study.Association between refill adherence to lipid-lowering medications and the risk of cardiovascular disease and mortality in Swedish patients with type 2 diabetes mellitus: a nationwide cohort study.12-year trends in cardiovascular risk factors (2002-2005 through 2011-2014) in patients with cardiovascular diseases: Tehran lipid and glucose study.Nonadherence to statins: individualized intervention strategies outside the pill box.Healthcare Utilization and Statin Re-Initiation Among Medicare Beneficiaries With a History of Myocardial Infarction.

P2860

Q28083004-0FD4B5F6-1F11-44D3-B52B-B091CDEFE912 Q30845413-6486FC19-291B-4A9F-8BFC-9412B3DD6204 Q33572803-6E607FD1-4147-4EF3-A49C-EB30B83947B2 Q33588629-D2635C7A-621C-4717-839B-C242E4974431 Q33647497-9471A34D-F11E-4FAE-B762-F8B4476D81C3 Q33665551-420660C8-28B8-490E-89BB-125C7CF6F27D Q34694318-D9EF73AF-3D78-495E-86EE-31DD944D7CEC Q36206941-421CECA0-2A04-4788-A9C9-0F4B42F2C189 Q36410456-1A4B1D5B-4B41-43A0-9827-08E43F518AB5 Q36773079-B8B5C766-EB7B-41A4-A1F3-D59B4AE5C752 Q37184508-B4E65E5B-E6F7-48A0-8278-CF13777304A4 Q37423203-FFF216D7-A720-4E9D-986F-648A177CFBA9 Q37515368-6903AE08-5573-41D0-8DE1-16A877C589D7 Q37579955-401DDECD-4B96-4416-A008-884F3CAEE98D Q37714650-3B8FFB9D-1FD5-4C65-96F7-B915A0A983B8 Q38420257-078A3DC8-28D9-4A0A-BCAF-E36725222890 Q38629283-94D302BF-58BC-4022-A5AE-785C72CB31B3 Q38646127-B0159F00-21B7-4517-A98A-272446631F20 Q38748686-75C6844C-F65C-4068-ACA0-E36A1BD302FB Q39026831-F154D2A4-8C01-4227-A465-40630A2D61DB Q40104818-1BED3DDF-C310-42D6-9B74-C10709AFCEEF Q40727728-490E61A8-8C22-4C56-997D-83B3B78151C0 Q42332407-8463382B-08F1-438E-B389-CC63B8790251 Q47113613-DF4C7336-CD6E-48E1-832A-D71B5D9A1812 Q47118074-024D1BB2-6F7B-486E-B564-6F2AC4AE853A Q47255965-F9614C8B-6718-4486-AADA-998DA9F874DF Q47571207-4FA76254-4328-4CD3-8597-65D427981449 Q48019632-1F760B7D-C6A7-4710-BCCE-47DA38D6834A Q48114521-5DCDB029-B25C-4626-85DE-4EE122F52712 Q49792621-105BE661-45CA-4A45-A713-4775079A84C9 Q49831991-8060E558-2F26-46A7-A15D-E01539622B8B Q50089764-E6D20660-DBF1-4BF0-A9F7-4AE54F2B073E Q53634402-EB87F491-25C6-4756-9586-82E1BEF5EE51 Q53833642-053865C8-CA73-4D90-ACD9-A968A5D7488F Q54952970-29747144-9D85-4CB1-A0F4-5F7934039FB3 Q55011566-3804348B-32C5-4D6C-8260-B8E8CDF2E112 Q55413700-5BBE9D40-8AD5-4C74-AC13-DFEF3E52DC18

P2860

Impact of statin adherence on cardiovascular disease and mortality outcomes: a systematic review

http://www.wikidata.org/entity/Q34554376

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Impact of statin adherence on ...... outcomes: a systematic review

@ast

Impact of statin adherence on ...... outcomes: a systematic review

@en

Impact of statin adherence on ...... outcomes: a systematic review

@nl

type

label

Impact of statin adherence on ...... outcomes: a systematic review

@ast

Impact of statin adherence on ...... outcomes: a systematic review

@en

Impact of statin adherence on ...... outcomes: a systematic review

@nl

prefLabel

Impact of statin adherence on ...... outcomes: a systematic review

@ast

Impact of statin adherence on ...... outcomes: a systematic review

@en

Impact of statin adherence on ...... outcomes: a systematic review

@nl

P1433

Q34554376-6B2363F9-851E-4EF6-90C9-F76067DED8F3

P1476

Q34554376-A7A108F8-E232-49B0-9049-8299EDC00F47

P2093

Q34554376-7CC53A9C-E3A8-4E69-A5EE-BD4F6BE36A00

Q34554376-D18BF233-C0E8-40FF-848E-3B97C3C83690

Q34554376-F432D687-45D8-4BEF-B674-1C5E889D0AAA

P2860

Q34554376-16D6D239-D029-4A39-8CE0-A17FBCBF8895

Q34554376-1832DCBC-9501-4D78-896D-CAD366115E53

Q34554376-26FEF8CF-C806-426B-8EE7-E109C169058C

Q34554376-2C28E423-6117-4792-90AA-B93E764F8040

Q34554376-2CBB5C14-C106-4172-8170-E61AD19EEDF4

Q34554376-3B1CC16C-BD67-4A45-A61A-2F3297622843

Q34554376-46EE5193-7B23-4E0B-9970-5EBE7F070C6A

Q34554376-48B4DEC8-166F-4249-9139-BF34A1CA8C11

Q34554376-4EACF7DA-8584-413F-B46C-548A0C198170

Q34554376-4FF54E6F-EC91-45A1-BBE9-939B7A3AF08A

P304

Q34554376-0C3821B9-CCA8-4B63-A883-D36F2C7B08D2

P31

Q34554376-8B3F0E42-3458-439A-BE1F-60D4CABFCCCE

P356

Q34554376-EDFF40CB-B7E9-4847-AE36-391FF53137D6

P407

Q34554376-A5925C0C-AB69-4E5A-B5DE-F17B55349D07

P433

Q34554376-C3C4A220-B38A-4A97-A268-B46ABD4AE7D5

P478

Q34554376-D72F948E-D571-4D0F-99F9-397A8FA3D3A2

P50

Q34554376-9D498E67-E43D-4D39-8B43-2448083215CC

P577

Q34554376-6605180C-7FA0-4BD1-8D41-A6352022C68C

P5875

Q34554376-B2EA37EA-767D-4F08-A27E-4C1A446BDE08

P698

Q34554376-742B6F56-BFA5-4165-8AA8-601C4B42C7F0

P921

Q34554376-8F3043FD-C1E1-42BF-8D74-63EB7A695F6F

P932

Q34554376-CDEF9BEA-0E1D-4690-8C92-B328EEE86BE9

P356

P1433

British Journal of Clinical Pharmacology

P1476

Impact of statin adherence on ...... outcomes: a systematic review

@en

P2093

Diane Lacaille

http://www.w3.org/2001/XMLSchema#string

Lindsay C Burns

http://www.w3.org/2001/XMLSchema#string

Vidula Bhole

http://www.w3.org/2001/XMLSchema#string

P2860

Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences

Effect of statins on the mortality of patients with ischaemic heart disease: population based cohort study with nested case-control analysis

Impact of medication therapy discontinuation on mortality after myocardial infarction

Adherence to cardioprotective medications and mortality among patients with diabetes and ischemic heart disease

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

Adherence to Medication

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

Adherence to statins is associated with reduced incidence of idiopathic venous thromboembolism: real-life data from a large healthcare maintenance organisation.

Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction.

P304

684-698

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BCP.12339

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

78

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260335153

http://www.w3.org/2001/XMLSchema#string

P698

25364801

http://www.w3.org/2001/XMLSchema#string

P921

cardiovascular disease

P932

4239963

http://www.w3.org/2001/XMLSchema#string